Medline (MDLN) FCF Margin (2025 - 2026)
Medline's (MDLN) quarterly FCF Margin came in at 7.86% in Q2 2026, up 660.0% year-over-year from 1.03% in Q2 2025, and up 82.86% quarter-over-quarter from 4.3% in Q1 2026.
Powered by 
Analysis
Medline (MDLN) FCF Margin (2025 - 2026) Analysis & Trends
Medline (MDLN) has reported FCF Margin for 2 consecutive years, with 7.86% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin rose 660.0% year-over-year to 7.86% in Q2 2026; TTM through Jun 2026 was 5.57%, a N/A change from a year earlier, with the FY2025 full-year figure at 4.56%, down 99.0% from the prior year.
- FCF Margin was 7.86% for Q2 2026 at Medline, up from 4.3% in the prior quarter.
- Over five years, FCF Margin peaked at 8.79% in Q1 2025 and troughed at 1.26% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 12.70% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 7.86% |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 9.26% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 6.11% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 29.65% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 19.22% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 8.41% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -24.47% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 7.86% |
| Mar 28, 2026 | 4.30% |
| Jun 28, 2025 | 1.26% |
| Mar 29, 2025 | 8.79% |